Your browser is no longer supported. Please, upgrade your browser.
Travere Therapeutics, Inc.
Index- P/E- EPS (ttm)-3.82 Insider Own0.90% Shs Outstand51.29M Perf Week-4.34%
Market Cap1.46B Forward P/E- EPS next Y-1.20 Insider Trans-4.83% Shs Float- Perf Month-8.71%
Income-188.80M PEG- EPS next Q-0.39 Inst Own89.50% Short Float- Perf Quarter-21.05%
Sales198.30M P/S7.34 EPS this Y-14.80% Inst Trans0.75% Short Ratio8.79 Perf Half Y19.11%
Book/sh4.12 P/B5.83 EPS next Y30.20% ROA-26.60% Target Price37.90 Perf Year49.63%
Cash/sh5.96 P/C4.03 EPS next 5Y- ROE-64.10% 52W Range14.50 - 33.09 Perf YTD-11.94%
Dividend- P/FCF- EPS past 5Y-26.80% ROI-41.30% 52W High-27.47% Beta0.66
Dividend %- Quick Ratio4.30 Sales past 5Y14.70% Gross Margin96.90% 52W Low65.52% ATR1.19
Employees262 Current Ratio4.40 Sales Q/Q9.20% Oper. Margin-88.80% RSI (14)41.12 Volatility3.79% 4.79%
OptionableYes Debt/Eq0.00 EPS Q/Q-238.50% Profit Margin-85.40% Rel Volume0.71 Prev Close23.97
ShortableYes LT Debt/Eq1.02 EarningsMay 06 AMC Payout- Avg Volume549.13K Price24.00
Recom1.30 SMA20-3.93% SMA50-8.43% SMA2000.94% Volume393,781 Change0.13%
Apr-27-21 04:30PM  
Apr-26-21 04:30PM  
Apr-14-21 07:24AM  
Mar-01-21 04:01PM  
Feb-25-21 08:00AM  
Feb-22-21 04:30PM  
Feb-18-21 04:30PM  
Feb-17-21 04:05PM  
Feb-16-21 04:30PM  
Feb-11-21 10:03PM  
Feb-10-21 04:01PM  
Feb-02-21 07:00AM  
Jan-12-21 04:30PM  
Jan-11-21 07:00AM  
Dec-01-20 04:30PM  
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASELAGE STEVEDirectorApr 16Option Exercise16.2310,000162,300198,940Apr 20 04:05 PM
ASELAGE STEVEDirectorApr 16Sale26.2310,000262,300188,940Apr 20 04:05 PM
ASELAGE STEVEDirectorMar 17Option Exercise16.2310,000162,300206,667Mar 19 04:05 PM
ASELAGE STEVEDirectorMar 17Sale27.4417,727486,456188,940Mar 19 04:05 PM